Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2023)
Kodiak Sciences (KOD) posted Amortizatization of Intangibles of $328000.0 for Q2 2023, down 36.68% on a QoQ basis from $518000.0 in Q1 2023, and up 4.46% year-over-year from $314000.0 in Q2 2022.
Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2023) Analysis & Trends
Kodiak Sciences' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $328000.0 for Q2 2023.
- Quarterly Amortizatization of Intangibles rose 4.46% year-over-year to $328000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $328000.0 (down 79.32% YoY) and the FY2023 annual result came in at $846000.0, down 20.79% from the prior year.
- Amortizatization of Intangibles was $328000.0 for Q2 2023 at Kodiak Sciences, down from $518000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $518000.0 in Q1 2023 and bottomed at -$356000.0 in Q2 2020.
- A 5-year average of $145400.0 and a median of $100000.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2020 — Amortizatization of Intangibles sank 456.0% — and 2022, when it soared 5333.33%.
- Kodiak Sciences' Amortizatization of Intangibles stood at $46000.0 in 2019, then sank by 304.35% to -$94000.0 in 2020, then soared by 93.62% to -$6000.0 in 2021, then soared by 5433.33% to $320000.0 in 2022, then gained by 2.5% to $328000.0 in 2023.
- Business Quant data shows KOD's Amortizatization of Intangibles at $328000.0 in Q2 2023, $518000.0 in Q1 2023, and $320000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Kodiak Sciences | 2.62 Bn | 2.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 328,000.00 |
| Jun 30, 2023 | 328,000.00 |
| Mar 31, 2023 | 518,000.00 |
| Mar 31, 2023 | 518,000.00 |
| Dec 31, 2022 | 320,000.00 |
| Dec 31, 2022 | 320,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Jun 30, 2022 | 314,000.00 |
| Jun 30, 2022 | 314,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Mar 31, 2021 | -19,000.00 |
| Mar 31, 2021 | -19,000.00 |
| Dec 31, 2020 | -94,000.00 |
| Dec 31, 2020 | -94,000.00 |
| Sep 30, 2020 | 376,000.00 |
| Sep 30, 2020 | 376,000.00 |
| Jun 30, 2020 | -356,000.00 |
| Jun 30, 2020 | -356,000.00 |